News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current RVVTF market cap is 8.79M. The company's latest EPS is CAD -0.0151 and P/E is -5.30.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.35M | -2.47M | -16.19M | -16.53M | -4.97M |
| Net Income | -1.34M | -5.38M | -20.12M | -17.81M | -6.32M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.28M | 8.26M | 29.81M | 17.07M | 14.25M |
| Total Liabilities | 322k | 831k | 999k | 4.46M | 3.6M |
| Total Equity | 960k | 7.43M | 28.81M | 12.6M | 10.65M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -1.18M | -2.52M | -8.31M | -13.06M | -6.03M |
| Investing | -751k | 142k | -2.72M | N/A | N/A |
| Financing | 1.35M | 3.28M | 26.25M | 376k | 4.2M |
| Market Cap | 8.79M |
| Price to Earnings Ratio | -5.30 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 16 |
| Price to Book Ratio | 3.14 |
| Dividend Yield | - |
| Shares Outstanding | 418.46M |
| Average Volume (1 week) | 254.85k |
| Average Volume (1 Month) | 191.04k |
| 52 Week Change | -70.42% |
| 52 Week High | 0.071 |
| 52 Week Low | 0.016 |
| Spread (Intraday) | 0.01 (25.6%) |
| Company Name | Revive Therapeutics Ltd (QB) |
| Address |
82 richmond street east toronto, ontario M5C 1P1 |
| Website | https://www.revivethera.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
